Evidence map›Paper›PMID 36855253›Full record

ArticleHIV medicine2023

Associations between alcohol and cigarette use and type 1 and 2 myocardial infarction among people with HIV.

Lydia N Drumright, Robin M Nance, Stephanie A Ruderman, Jimmy Ma, Bridget M Whitney, Andrew Hahn, Rob J Fredericksen, Brandon Luu, William B Lober, Richard D Moore and 21 more

Open access · hybridAbstract read
In one paragraph

Article in HIV medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 11 institutions in 3 countries.

Lydia N DrumrightUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-3361-8080
Robin M NanceUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-4412-4844
Stephanie A RudermanUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-0058-5729
Jimmy MaUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-6849-3206
Bridget M WhitneyUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-3738-5704
Andrew HahnUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-9552-1700
Rob J FredericksenUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0003-3936-7048
Brandon LuuNorthern Ontario School of Medicine, Thunder Bay, Ontario, Canada.ORCID 0000-0002-7203-5283
William B LoberUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-1053-7501
Richard D MooreJohns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0001-8250-5069
Matthew J BudoffUniversity of California, Los Angeles, California, USA.ORCID 0000-0002-9616-1946
Jeanne C KerulyJohns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0002-8489-435X
Katerina ChristopoulosUniversity of California, San Francisco, California, USA.ORCID 0000-0002-8598-2191
Sarah PuryearUniversity of California, San Francisco, California, USA.ORCID 0000-0003-0669-3293
Amanda WilligUniversity of Alabama, Birmingham, Alabama, USA.ORCID 0000-0001-8802-4311
Karen CropseyUniversity of Alabama, Birmingham, Alabama, USA.ORCID 0000-0001-6921-3440
William C MathewsUniversity of California, San Diego, California, USA.ORCID 0000-0002-2352-0725
Edward CachayUniversity of California, San Diego, California, USA.ORCID 0000-0002-2452-7558
Laura BamfordUniversity of California, San Diego, California, USA.ORCID 0000-0001-5988-8372
Joseph J EronUniversity of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-4938-0644
Sonia NapravnikUniversity of North Carolina, Chapel Hill, North Carolina, USA.ORCID 0000-0002-9032-3713
Kenneth H MayerHarvard University, Cambridge, Massachusetts, USA.ORCID 0000-0001-7460-733X
Conall O'CleirighHarvard University, Cambridge, Massachusetts, USA.ORCID 0000-0002-5639-5043
Mary E MccaulJohns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0003-2009-4115
Geetanjali ChanderUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-2216-6330
Matthew J FeinsteinNorthwestern University, Evanston, Illinois, USA.ORCID 0000-0002-8958-7666
Michael S SaagUniversity of Alabama, Birmingham, Alabama, USA.ORCID 0000-0002-8866-1043
Mari M KitahataUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-5410-7175
Susan R HeckbertUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-7100-512X
Heidi M CraneUniversity of Washington, Seattle, Washington, USA.ORCID 0000-0002-3308-7005
Joseph A C DelaneyUniversity of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-1771-1776
University of Washington · USJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of California San Diego · USHarvard University Press · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USNorthwestern University · USNOSM University · CAUniversity of California, Los Angeles · USUniversity of Manitoba · CA

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
Alcohol Research Consortium in HIV: Relapse Prevention ArmP01AA029544 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI HUTTON, HEIDI · 2021 to 2025
$7.1M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Substance use patterns and contexts: impact on epigenetic age and prevention strategies in an HIV clinical care cohortR01DA047045 · NIDA · UNIVERSITY OF WASHINGTON · PI Heidi M. Crane, Joseph Austin Delaney · 2018 to 2026
$5.1M
Links between Cardiovascular disease, Lung disease, and Obstructive sleep apnea in HIV: Understanding complex patientsR01HL126538 · NHLBI · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., CROTHERS, KRISTINA ANNE · 2015 to 2025
$5.1M
HIV and Aging Research Consortium (HARC)R33AG067069 · NIA · UNIVERSITY OF WASHINGTON · PI STEVEN N. AUSTAD, Heidi M. Crane · 2020 to 2026
$4.8M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
NHLBI NIH HHS R01 HL125027NHLBI NIH HHS R01 HL126538NIAAA NIH HHS K23 AA029045NIAAA NIH HHS P01 AA029544NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS R24 AI067039NIA NIH HHS R33 AG067069NIDA NIH HHS K24 DA062568NIDA NIH HHS R01 DA044112NIDA NIH HHS R01 DA047045NIDA NIH HHS U24 DA058307NIH HHSNIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

objectivesPeople with HIV have a higher risk of myocardial infarction (MI) than the general population, with a greater proportion of type 2 MI (T2MI) due to oxygen demand-supply mismatch compared with type 1 (T1MI) resulting from atherothrombotic plaque disruption. People living with HIV report a greater prevalence of cigarette and alcohol use than do the general population. Alcohol use and smoking as risk factors for MI by type are not well studied among people living with HIV. We examined longitudinal associations between smoking and alcohol use patterns and MI by type among people living with HIV. DESIGN AND

methodsUsing longitudinal data from the Centers for AIDS Research Network of Integrated Clinical Systems cohort, we conducted time-updated Cox proportional hazards models to determine the impact of smoking and alcohol consumption on adjudicated T1MI and T2MI.

resultsAmong 13 506 people living with HIV, with a median 4 years of follow-up, we observed 177 T1MI and 141 T2MI. Current smoking was associated with a 60% increase in risk of both T1MI and T2MI. In addition, every cigarette smoked per day was associated with a 4% increase in risk of T1MI, with a suggestive, but not significant, 2% increase for T2MI. Cigarette use had a greater impact on T1MI for men than for women and on T2MI for women than for men. Increasing alcohol use was associated with a lower risk of T1MI but not T2MI. Frequency of heavy episodic alcohol use was not associated with MI.

conclusionsOur findings reinforce the prioritization of smoking reduction, even without cessation, and cessation among people living with HIV for MI prevention and highlight the different impacts on MI type by gender.

Indexed as

HIV InfectionsMyocardial InfarctionPlaque, AtheroscleroticTobacco ProductsFemaleHumansMaleRisk Factorsalcohol usebinge drinkingHIVpeople with HIVsmokingtype 1 myocardial infarctiontype 2 myocardial infarction

Identifiers

PMID36855253
PMCPMC10330202
OpenAlexW4322719683

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.